scholarly journals PALINA: A phase II safety study of palbociclib in combination with letrozole or fulvestrant in African American women with hormone receptor positive HER2 negative advanced breast cancer

2018 ◽  
Vol 10 ◽  
pp. 190-192
Author(s):  
Filipa Lynce ◽  
Mervat Saleh ◽  
Ayesha Shajahan-Haq ◽  
Christopher Gallagher ◽  
Asma Dilawari ◽  
...  
Keyword(s):  
Breast Cancer ◽  
African American ◽  
Advanced Breast Cancer ◽  
African American Women ◽  
Phase Ii ◽  
Hormone Receptor ◽  
Advanced Breast ◽  
Safety Study ◽  
American Women ◽  
Hormone Receptor Positive

scholarly journals Phase II Study of Taselisib (GDC-0032) in Combination with Fulvestrant in Patients with HER2-Negative, Hormone Receptor–Positive Advanced Breast Cancer

2018 ◽  
Vol 24 (18) ◽  
pp. 4380-4387 ◽  
Author(s):  
Maura N. Dickler ◽  
Cristina Saura ◽  
Donald A. Richards ◽  
Ian E. Krop ◽  
Andrés Cervantes ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Advanced Breast Cancer ◽  
Phase Ii ◽  
Hormone Receptor ◽  
Phase Ii Study ◽  
Advanced Breast ◽  
Hormone Receptor Positive

Prevention of stomatitis in patients with hormone receptor–positive advanced breast cancer treated with everolimus plus exemestane: A phase II study of a steroid-based mouthwash.

2014 ◽  
Vol 32 (15_suppl) ◽  
pp. TPS661-TPS661 ◽  
Author(s):  
Hope S. Rugo ◽  
Mark Steven Chambers ◽  
Jennifer Keating Litton ◽  
Ingrid A. Mayer ◽  
Jaqueline Willemann Rogerio ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Advanced Breast Cancer ◽  
Phase Ii ◽  
Hormone Receptor ◽  
Phase Ii Study ◽  
Advanced Breast ◽  
Hormone Receptor Positive
Sign in / Sign up

Export Citation Format

Share Document